So the strength benefits happen at 500 milligrams
Cagrilintide (2.5mg) / GLP-1 S (2.5mg) Price range: $100.00 through $150.00 Description A two-component co-formulation of Cagrilintide and a GLP-1class peptide supplied for controlled research environments
Phase 3 ACHIEVE-1 trial results for orforglipron, as discussed by Rosenstock and colleagues, demonstrated that this once-daily oral small molecule GLP-1 achieved statistically significant reductions in HbA1c (1.3% to 1.6% from a baseline of 8.0%) compared to placebo in adults with type 2 diabetes
Rosenstock J, Wysham C, Frias JP, Kaneko S, Lee CJ, Fernandez Lando L, Mao H, Cui X, Karanikas CA, Thieu VT
This work was funded by the Jiangsu Agricultural Science and Technology Innovation Fund [CX (21) 2014], Natural Science Foundation of Jiangsu Province (BK20220582 and BK20210812), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
Patent Number: MDA19-063 - (Japanese patent pending)